Daniel R Carter

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Dna Methylation

Histone Deacetylase

Genome Wide Identification

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jayne E Murray, Emanuele Valli, Giorgio Milazzo, Chelsea Mayoh, Andrew J Gifford, Jamie I Fletcher, Chengyuan Xue, Nisitha Jayatilleke, Firoozeh Salehzadeh, Laura D Gamble, Jourdin R C Rouaen, Daniel R Carter, Helen Forgham, Eric O Sekyere, Joanna Keating, Georgina Eden, Sophie Allan, Stephanie Alfred, Frances K Kusuma, Ashleigh Clark, Hannah Webber, Amanda J Russell, Antoine deWeck, Benjamin T Kile, Martina Santulli, Piergiuseppe De Rosa, Emmy D G Fleuren, Weiman Gao, Lorna Wilkinson-White, Jason K K Low, Joel P Mackay, Glenn M Marshall, Douglas J Hilton, Federico Manuel Giorgi, Jan Koster, Giovanni Perini, Michelle Haber, Murray D Norris
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis. Nature communications 15 (1) (2024)
Jayne E Murray, Emanuele Valli, Giorgio Milazzo, Chelsea Mayoh, Andrew J Gifford, Jamie I Fletcher, Chengyuan Xue, Nisitha Jayatilleke, Firoozeh Salehzadeh, Laura D Gamble, Jourdin R C Rouaen, Daniel R Carter, Helen Forgham, Eric O Sekyere, Joanna Keating, Georgina Eden, Sophie Allan, Stephanie Alfred, Frances K Kusuma, Ashleigh Clark, Hannah Webber, Amanda J Russell, Antoine deWeck, Benjamin T Kile, Martina Santulli, Piergiuseppe De Rosa, Emmy D G Fleuren, Weiman Gao, Lorna Wilkinson-White, Jason K K Low, Joel P Mackay, Glenn M Marshall, Douglas J Hilton, Federico Manuel Giorgi, Jan Koster, Giovanni Perini, Michelle Haber, Murray D Norris
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis. Nature communications 15 (1) (2024)
Jayne E Murray, Emanuele Valli, Giorgio Milazzo, Chelsea Mayoh, Andrew J Gifford, Jamie I Fletcher, Chengyuan Xue, Nisitha Jayatilleke, Firoozeh Salehzadeh, Laura D Gamble, Jourdin R C Rouaen, Daniel R Carter, Helen Forgham, Eric O Sekyere, Joanna Keating, Georgina Eden, Sophie Allan, Stephanie Alfred, Frances K Kusuma, Ashleigh Clark, Hannah Webber, Amanda J Russell, Antoine deWeck, Benjamin T Kile, Martina Santulli, Piergiuseppe De Rosa, Emmy D G Fleuren, Weiman Gao, Lorna Wilkinson-White, Jason K K Low, Joel P Mackay, Glenn M Marshall, Douglas J Hilton, Federico Manuel Giorgi, Jan Koster, Giovanni Perini, Michelle Haber, Murray D Norris
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis. Nature communications 15 (1) (2024)
Alice Salib, Nisitha Jayatilleke, Janith A Seneviratne, Chelsea Mayoh, Katleen De Preter, Frank Speleman, Belamy B Cheung, Daniel R Carter, Glenn M Marshall
MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression. Oncogene (2023)
Belamy B Cheung, Ane Kleynhans, Rituparna Mittra, Patrick Y Kim, Jessica K Holien, Zsuzsanna Nagy, Olivia C Ciampa, Janith A Seneviratne, Chelsea Mayoh, Mukesh Raipuria, Satyanarayana Gadde, Hassina Massudi, Iris Poh Ling Wong, Owen Tan, Andrew Gong, Aldwin Suryano, Sonya M Diakiw, Bing Liu, Greg M Arndt, Tao Liu, Naresh Kumar, Olle Sangfelt, Shizhen Zhu, Murray D Norris, Michelle Haber, Daniel R Carter, Michael W Parker, Glenn M Marshall
A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma. Oncogene 40 (13) (2021)
Zsuzsanna Nagy, Janith A Seneviratne, Maxwell Kanikevich, William Chang, Chelsea Mayoh, Pooja Venkat, Yanhua Du, Changhong Wang, Alice Salib, Jessica Koach, Daniel R Carter, Rituparna Mittra, Tao Liu, Michael W Parker, Belamy B Cheung, Glenn M Marshall
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability. Nature communications 12 (1) (2021)